home > news > in the news
TriOptima in the news


  • 10 Jun 2013 Financial Times Tech Beat: Market gets creative to beat the margin squeeze
    • One of the trickiest issues banks and brokers will face in coming years is finding the collateral, or insurance, they need to back their trades. All recognise they will need more for trading when the wave of competing financial services regulation kicks in; few know how much will be required, nor what will be acceptable to both regulators and clearing houses.
  • 06 Jun 2013 Boersen Zeitung Die Abstimmung der Portfolios wird Pflicht
    • Die von der Finanzkrise angestoßene Regulierungswelle wird weitreichende Folgen für den außerbörslichen (OTC) Derivatehandel haben.
  • 06 Mar 2013 Asset Servicing Times Tri as sides might
    • Susan Hinko, David White and James Hollands of TriOptima talk to AST about counterparty exposure management.
  • 21 Feb 2013 Jiji.com 時事ドットコム
    • 円金利スワップの解消を仲介-トライオプティマ
  • 04 Feb 2013 Financial Times TriOptima uses gaming to measure risk
    • TriOptima, a Swedish trading technology group, has turned to chips used to power games such as Tour of Duty, Batman: Arkham Asylum and Assassin’s Creed to measure dry financial calculations like credit value adjustments, the value of risk weighted assets and potential future exposures.
  • 20 Dec 2012 Financial Times Clearing Risk
    • [Video] Mireille Dyrberg, chief operating officer with post-trade service company TriOptima, explains to FT Trading Room editor Philip Stafford how 'tearing up' of long-dated contracts can limit those exposures.
  • 03 Nov 2012 International Financing Review Reconciliation to the fore as regulations bite
    • Participants in the over-the-counter derivatives market are increasing their focus on portfolio reconciliation ahead of mandatory regulations set to take hold in the US next week and Europe in 2013. [SUBSCRIPTION]
  • 29 Oct 2012 Asset Servicing Times J.P. Morgan offers daily portfolio reconciliation
    • J.P. Morgan’s Agency Clearing, Collateral Management and Execution (ACCE) business has introduced daily portfolio reconciliation for its derivatives collateral management clients.
  • 01 Jul 2012 Risk Risk25 - Firms of the Future
    • Risk picks the dealers, buy-side firms, brokers, exchanges, technology vendors, clearing houses, regulators, infrastructure providers and trading platforms they believe will be the most influential firms over the next five years.
  • 06 Jun 2012 ISDA Adjusted OTC Derivatives Volume Declines and Central Clearing Increases, According to ISDA Market Analysis
    • According to the ISDA analysis, adjusted volumes of OTC derivatives declined by 10.3 percent from June 2011 to $440 trillion.
  • 04 Jun 2012 Bank of Japan Wrong-way risk in OTC derivatives and its implication for Japan's financial institutions
    • The size of the market for OTC derivatives has been growing rapidly, including in Japan, and upgrading the counterparty risk management through strengthened collateral managements has become a pressing matter for the financial institutions that frequently use these transactions.
  • 01 Jun 2012 Energy Risk TriOptima wins Technology House of the Year Award
    • TriOptima wins our Technology House of the Year award for its innovative triReduce and triResolve technologies, which have been gaining traction in the energy space over the past year.
  • 01 Jun 2012 ISS Magazine Proactive management
    • Raf Pritchard, CEO of TriOptima’s exposure management service, talks about triResolve and buy side adoption of the innovative exposure management services.
  • 28 May 2012 Derivatives Intelligence Maximizing Interest Rate Portfolio Compression
    • Portfolio compression has become an important tool for managing counterparty risk exposure and reducing operational costs and risks in OTC derivatives portfolios. [SUBSCRIPTION]
  • 18 May 2012 Institutional Investor Does Dodd-Frank Need Algorithmic Help on OTC Derivative Risk?
    • While the debate over the impact of new regulations to the over-the-counter derivatives market continues apace, at least one technology provider says they have come up with a way to dramatically reduce systemic risk in this arena.
  • 05 Mar 2012 Wall Street Journal Decommissioning Derivatives Weapons
    • Big numbers can be scary, especially when it comes to $700 trillion in derivatives. At least, though, some financial firms are trying to whittle down that ginormous figure.
  • 23 Feb 2012 ISDA Interest Rate Swaps Compression: A Progress Report
    • The paper describes portfolio compression, a risk reduction technique that was introduced to the interest rate swap (IRS) market by TriOptima in 2003. It also highlights how compression could be optimized via the “one-book” approach to achieve even larger reductions in IRS notionals for cleared and uncleared swaps.
  • 13 Feb 2012 Kinzai Institute for Financial Affairs Approach for Portfolio Compression and Collateral Management
    • The G-20 nations agreed to strengthen OTC derivatives markets regulation, including central clearing, following the collapse of Lehman Brothers. Simultaneously, portfolio compression and portfolio reconciliation, which complement central clearing, have been more widely accepted globally, and Japanese financial institutions have started to use these tools more.
  • 01 Aug 2011 Financial News Politics has not stopped sovereign CDS appetite
    • There is no doubt about what the predominating influence on the credit default swap market is at the moment – if not, indeed, on the entire capital market. “It’s the sovereigns that are leading the rest of the market,” said a CDS broker recently. [SUBSCRIPTION]
  • 21 Jul 2011 ISDA ISDA Marks First Anniversary of Dodd-Frank Act: Clearing, Transparency Drive Improvements in OTC Derivatives Markets
    • At the first anniversary of the Dodd-Frank Act, market participants, policymakers and others are assessing the safety of the over-the-counter (OTC) derivatives markets in light of the legislation as well as efforts the industry has undertaken over the past few years in conjunction with global regulators.
1 2
time
New York office
+1 646 744 0400
time
London office
+44 20 7382 2200
time
Stockholm office
+46 8 545 25 130
time
Singapore office
+65 6372 8181
time
Tokyo office
+81 3 6450 1350
TriOptima logo
 

© 2004-2013 TriOptima AB, an ICAP Group Company. All rights reserved | Terms of use | Privacy statement | Site map | Info security Site build
Please enter your full name.

Disclaimer
Interest Rate Trade Reporting Repository
Terms and Conditions for Access and Use


1. Scope of Agreement
    These terms and conditions (this "Agreement") govern your access to and use of any public repository reports of OTC interest rate derivatives (each a "Report") produced by TriOptima AB ("TriOptima"), as described on the information web page regarding the repository. You must accept this Agreement to access and use Reports. You accept the Agreement by clicking the "I Agree" button on the bottom of this page. TriOptima may at any time, without advance or specific notice, amend this Agreement. Hence, you are expected to review and accept this Agreement each time you wish to access any Report through this website.


2. Intellectual property rights, license to use
    You acknowledge that TriOptima is the sole and exclusive owner of any and all intellectual property rights to the structure and layout of any Report.


    TriOptima hereby grants to you a non-exclusive license to use Reports in accordance with this Agreement.


3. Prohibited use of Reports
    You must not use any Report or the information contained in any Report in a manner that may harm or be detrimental to TriOptima, including without limitation, to use any Report to directly or indirectly compete or promote competition with TriOptima.


    You are not allowed to use TriOptima's name or any trademarks, trade names or service marks contained in any Report or this website in advertising, publicity or otherwise; neither are you allowed to copy any marks, specific characteristics or attributes of any Report for any other purpose than for making a lawful and contractually permitted copy of a Report.


4. Non-reliance, no warranty, disclaimer
    Each Report is provided to you free of charge. However, TriOptima does not warrant or undertake to make any Reports available to you; hence you acknowledge that TriOptima, in its sole discretion, may or may not make Reports available to you via this website or otherwise.


    Each Report is intended for information purposes only. Any information in a Report may at any time be superseded or replaced by new or updated information. Furthermore, the information contained in a Report is based on the information submitted by third parties for the purpose of inclusion in such Report. The information contained in a Report is neither checked, nor verified by TriOptima. Consequently, you acknowledge that Reports are for information purposes only, that they may not be relied upon for any purpose whatsoever, and that they are dependent upon, as regards their accuracy and completeness, the data submitted to TriOptima by third parties.


    The parties acknowledge that TriOptima makes no representation or warranty with respect to any Report or this website or any data or materials retrieved, obtained, provided or transmitted, by or to you, using this website. Each Report and this website and all such data and materials are being provided to you "as is". TriOptima hereby disclaims any and all representations and warranties, whether express or implied, including without limitation, any representation or warranty as to merchantability or fitness for a particular purpose, any representations or warranties arising from course of dealing or course of performance, and any representations or warranties of accuracy, reliability or functionality.


    To the maximum extent permitted by law, TriOptima disclaims all liability arising out of or in connection with the use of any Report or this website.

    Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.


    Notwithstanding anything to the contrary in this Agreement, TriOptima does not exclude or limit its liability for wilful misconduct, fraud or death or personal injury arising from TriOptima's negligence.


    For purposes of this clause, references to TriOptima shall be deemed to include its affiliates and their respective partners, officers, employees, directors, agents, contractors, representatives, successors and assigns.


5. Viruses, malware
    To the best of TriOptima's knowledge, Reports published on this website, this website and the server on which it resides are free from viruses and other malware. However, TriOptima cannot warrant this to be the case, and it is your responsibility to take precautions to prevent your computer and/or network to be affected by viruses or other malware. Hence, TriOptima does not assume any liability for any damage or loss, whether direct or indirect, including loss of data, caused to you by viruses or other malware from Reports published on this website, this website or the server on which it resides, including when you download any Report.


6. Applicable law, disputes
    This Agreement and any non-contractual obligations arising in connection with it shall be governed by English law, without regard to its principles of conflicting laws. Each party submits to the exclusive jurisdiction of the English courts for all purposes relating to this Agreement (including the enforcement of any determinations).
I agree    I decline